These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3381527)

  • 1. [Urinary fibrinolytic enzyme activity in systemic diseases and chronic glomerulonephritis].
    Palienko IA; Belitskaia GA
    Vrach Delo; 1988 Feb; (2):71-3. PubMed ID: 3381527
    [No Abstract]   [Full Text] [Related]  

  • 2. [Urinary urokinase and blood fibrinolytic activity in patients with nephrolithiasis and other urinary tract diseases].
    Kotschy M; Lorenz T; Kaniak J; Janukowicz-Lorenz H; Lorenz J; Dabrowska B
    Pol Tyg Lek; 1975 Oct; 30(43):1773-7. PubMed ID: 52868
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fibrinolytic activity of the urine during chronic glomerulonephritis and amyloidosis].
    Podorol'skaia LV; Andreenko GV; Poliantseva LR; Bumblite ID
    Vopr Med Khim; 1999; 45(2):158-64. PubMed ID: 10378306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Disorders of the fibrinolytic activity of urine in certain kidney diseases].
    Karastanev I; Atanasov K
    Urol Nefrol (Mosk); 1976; (3):19-21. PubMed ID: 973260
    [No Abstract]   [Full Text] [Related]  

  • 5. [Urokinase excretion and fibrinolysis in infectious kidney diseases].
    Bachmann HJ; Tacke E; Haupt H
    Monatsschr Kinderheilkd (1902); 1974 Jul; 122(7):567-8. PubMed ID: 4411414
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
    Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
    J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood urokinase plasminogen activator system in chronic urticaria.
    Kasperska-Zajac A; Brzoza Z; Rogala B
    Arch Dermatol Res; 2007 Jan; 298(8):409-11. PubMed ID: 17102952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urinary urokinase and blood fibrinolytic activity in patients with diabetes mellitus].
    Kaniak J; Kotschy M; Janukowicz-Lorenz H; Plamieniak L
    Pol Tyg Lek; 1975 Dec; 30(48):1889-91. PubMed ID: 1197079
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical effect of urokinase on chronic glomerulonephritis (group study).
    Abe T
    New Istanbul Contrib Clin Sci; 1978 Mar; 12(2):123-32. PubMed ID: 16302698
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of plasma urokinase-type plasminogen activator and urokinase-type plasminogen-activator receptor in patients with acute and chronic hepatitis B.
    Zhou H; Wu X; Lu X; Chen G; Ye X; Huang J
    Thromb Res; 2009; 123(3):537-42. PubMed ID: 18691743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Urina urokinase and blood fibrinolytic activity in w experimental zinc poisoning].
    Guja A
    Patol Pol; 1977; 28(2):201-8. PubMed ID: 887291
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of urokinase inhibitors on effective fibrinolytic activity of human urine].
    Potapenko VE; Shataeva LK
    Vopr Med Khim; 1994; 40(1):37-8. PubMed ID: 8122409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Urinary fibrinolytis activity and the blood coagulation system in chronic pyelonephritis].
    Khvan PT
    Urol Nefrol (Mosk); 1980; (1):10-3. PubMed ID: 7368430
    [No Abstract]   [Full Text] [Related]  

  • 14. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy].
    Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y
    J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Urine fibrinolytic activity as an indicator of kidney damage in uric acid metabolic imbalance].
    Shcherbak AV; Balkarov IM; Kozlovskaia LV; Podorol'skaia LV; Gindis AA
    Ter Arkh; 2001; 73(6):34-7. PubMed ID: 11521518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activators and inhibitor type-1 in alveolar osteitis.
    Serratì S; Margheri F; Bruschi S; D'Alessio S; Pucci M; Fibbi G; Tonelli P; Del Rosso M
    Eur J Oral Sci; 2006 Dec; 114(6):500-3. PubMed ID: 17184232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The levels of fibrinopeptide A and fibrinopeptide B beta in the urine from patients with chronic glomerulonephritis during urokinase therapy].
    Miura M; Tomino Y; Inoue W; Tamura S; Nomoto Y; Sakai H; Itoh K
    Rinsho Byori; 1985 Jun; 33(6):652-6. PubMed ID: 4032804
    [No Abstract]   [Full Text] [Related]  

  • 18. Changes in pericardial morphology and fibrinolytic activity during cardiopulmonary bypass.
    Nkere UU; Whawell SA; Thompson EM; Thompson JN; Taylor KM
    J Thorac Cardiovasc Surg; 1993 Aug; 106(2):339-45. PubMed ID: 8341074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excess soluble urokinase-type plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activity.
    Pawlak K; Pawlak D; Mysliwiec M
    Thromb Res; 2007; 119(4):475-80. PubMed ID: 16828495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
    Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V
    Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.